Pelican BioThermal Commits to Support Diabetes Research and Awareness

Pelican BioThermal, the global name in cold chain, announces a company-wide philanthropic initiative to support diabetes awareness and research.

According to the American Diabetes Association, 29.1 million Americans (nearly 10% of the U.S. population) have diabetes and as many as 1.25 million of those have type 1 diabetes, requiring daily doses of insulin. The drug is not only costly, with prices rising steadily over the past decade, but to remain effective, insulin vials must also be kept cool—a challenge that Pelican BioThermal regularly addresses.

"Our products, including the Credo Cube™, are uniquely suited to maintain the temperature stability necessary to transport vital diabetic drugs. However, meeting temperature requirements for these drugs is only one component of an overall global health issue," explained Adam Tetz, director of worldwide marketing at Pelican BioThermal. "Contributing to research and raising awareness about diabetes, a condition which affects more than 400 million people worldwide, is critical."

Over the last year, Pelican BioThermal has participated in events with the American Diabetes Association, including participation in and sponsorship of the 2017 Twin Cities Tour de Cure, the organization's premier cycling fundraising event.

The temperature controlled packaging leader also partnered with "For A Piece Of Cake," a cycling challenge undertaken by riders Chiara Ricciardi and Riccardo Rocchi to help raise awareness of diabetes. Over the last year, Ricciardi, who has type 1 diabetes, and Riccardo covered a total of nearly 11,185 miles from Cesena, Italy to Singapore via bicycles. To maintain temperature stability of Ricciardi's vital diabetic drugs, Pelican BioThermal supplied the pair with their Cr?do™ ProMed, a robust, temperature controlled portable medical transport bag designed for emergency first responders and medical couriers to ensure delicate pharmaceuticals remain safely intact.

To learn more Pelican BioThermal's philanthropic efforts, including work with the American Diabetes Association and "For A Piece of Cake," visit http://PelicanBioThermal.com/news.

Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

###

About Pelican Products
Pelican Products, Inc. is the global leader in the design and manufacture of high performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals in the most demanding markets including fire safety, law enforcement, defense / military, aerospace, entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime. The company operates in 21 countries, with 22 international sales offices and six manufacturing facilities around the globe. In Europe, the company does business under the name Peli Products, S.LU. For more information, visit pelican.com orbehrmancap.com.

About Pelican BioThermal
Pelican BioThermal LLC offers the widest range of thermally protected, temperature controlled packaging and service solutions to the global life sciences industry. The company's products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. The company's customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature controlled packaging asset management. In Europe, the company does business under the name Peli BioThermal Limited. For more information, visit pelicanbiothermal.com.

More Info: http://pelicanbiothermal.com/news/pelican-biothermal-commits-support-diabetes-research-and-awareness